Tag: FDA
-
FDA Issues Statement on PFAS in Food
The U.S. Food and Drug Administration (FDA) has issued a statement on per- and polyfluoroalkyl substances (PFAS) in food following a presentation published in the media that indicated the agency found the substances in meat, fish and chocolate. “Overall, our findings did not detect PFAS in the vast majority of the foods tested,” the statement…
-
Guidance Finalized for Added Sugar Labeling in Syrups
The U.S. Food and Drug Administration has finalized guidance on labeling for added sugars in single-ingredient packages of “pure honey, pure maple syrup, and other pure sugars and syrups, which are not required to bear the words ‘Includes Xg Added Sugars’ but must still include the percent Daily Value (DV) for added sugars on their…
-
FDA Proposes Third-Party Food Safety Certification
The U.S. Food and Drug Administration (FDA) has indicated that it will seek public comment on a proposal that would allow the accreditation of third-party certification bodies “to conduct food safety audits of eligible foreign food facilities, and issue food and facility certifications, pursuant to the FDA Food Safety Modernization Act.” The notice responds to…
-
Dietary Guidelines Meetings Announced
The U.S. Department of Agriculture and Health and Human Services have announced meetings to hear public comments on the 2020 dietary guidelines revisions. The 2020 Dietary Guidelines Advisory Committee will allow three-minute pre-registered comments from the public at its meetings on July 11, 2019, and January 25, 2020, and registration for the July meeting closes…
-
FDA Recommends Standardized Use of “Best If Used By”
The U.S. Food and Drug Administration (FDA) has sent a letter to food and beverage manufacturers recommending that they primarily use “Best If Used By” on their packages to help consumers who may be confused by the use of the phrase “Sell By.” The letter explains that the Grocery Manufacturers Association and Food Marketing Institute…
-
FDA Holds Public Meeting on Cannabis
On May 31, 2019, the U.S. Food and Drug Administration (FDA) held a widely anticipated public hearing with stakeholders on cannabis and cannabis-derived compounds to gain insights on product safety and a potential regulatory framework for products containing such substances. The hearing focused on cannabidiol (CBD)—a popular but controversial compound that has been added to…
-
FDA Issues Guidance on “Potassium Chloride Salt”
The U.S. Food and Drug Administration (FDA) has issued draft guidance for industry on the use of “potassium chloride salt” on food labels as an acceptable alternative to the use of the common or usual name “potassium chloride.” The guidance indicates that the agency recognizes that food manufacturers “wishing to reduce sodium chloride in their…
-
FDA Draft Guidance Excludes Allulose from Added Sugar Disclosure
The U.S. Food and Drug Administration (FDA) has issued draft guidance allowing food manufacturers to exclude allulose when calculating the amount of added sugars a product contains. Allulose is “approximately 70 percent as sweet as sucrose,” according to a comment FDA received, and “does not have the metabolic properties of fructose or other sugars and…